Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Celeghini

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Cellular Physiology|October 31, 2009
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL)Giorgio Zauli, Erika Rimondi, Claudio Celeghini, et al.
Nutrition Research Reviews|September 12, 2024
Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity?Domenico Sergi, Enrico Zauli, Claudio Celeghini, et al.
Frontiers in Immunology|March 5, 2021
Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis DevelopmentDavide Ferrari, Andrea la Sala, Daniela Milani, et al.
International Journal of Molecular Sciences|May 5, 2021
MitoQ Is Able to Modulate Apoptosis and InflammationElisa Piscianz, Alessandra Tesser, Erika Rimondi, et al.
Cellular Signalling|January 8, 2004
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cellsValeria Bertagnolo, Federica Brugnoli, Marco Marchisio, et al.
British Journal of Haematology|February 9, 2012
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to DasatinibPaola Secchiero, Elisabetta Melloni, Rebecca Voltan, et al.
Blood|June 24, 2004
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSFGiorgio Zauli, Erika Rimondi, Vanessa Nicolin, et al.
Current Pharmaceutical Design|August 12, 2008
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignanciesPaolo Macor, Erika Secco, Sonia Zorzet, et al.
International Journal of Molecular Sciences|February 25, 2023
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and LimitationsMatteo Fields, Annalisa Marcuzzi, Arianna Gonelli, et al.
Taiwanese Journal of Obstetrics & Gynecology|July 15, 2014
Potential role of circulating microRNAs as early markers of preeclampsiaBlendi Ura, Giordana Feriotto, Lorenzo Monasta, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Cellular Physiology|October 31, 2009
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL)Giorgio Zauli, Erika Rimondi, Claudio Celeghini, et al.
Nutrition Research Reviews|September 12, 2024
Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity?Domenico Sergi, Enrico Zauli, Claudio Celeghini, et al.
Frontiers in Immunology|March 5, 2021
Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis DevelopmentDavide Ferrari, Andrea la Sala, Daniela Milani, et al.
International Journal of Molecular Sciences|May 5, 2021
MitoQ Is Able to Modulate Apoptosis and InflammationElisa Piscianz, Alessandra Tesser, Erika Rimondi, et al.
Cellular Signalling|January 8, 2004
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cellsValeria Bertagnolo, Federica Brugnoli, Marco Marchisio, et al.
British Journal of Haematology|February 9, 2012
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to DasatinibPaola Secchiero, Elisabetta Melloni, Rebecca Voltan, et al.
Blood|June 24, 2004
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSFGiorgio Zauli, Erika Rimondi, Vanessa Nicolin, et al.
Current Pharmaceutical Design|August 12, 2008
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignanciesPaolo Macor, Erika Secco, Sonia Zorzet, et al.
International Journal of Molecular Sciences|February 25, 2023
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and LimitationsMatteo Fields, Annalisa Marcuzzi, Arianna Gonelli, et al.
Taiwanese Journal of Obstetrics & Gynecology|July 15, 2014
Potential role of circulating microRNAs as early markers of preeclampsiaBlendi Ura, Giordana Feriotto, Lorenzo Monasta, et al.
Pageof 6